Diprotin A | CAS:90614-48-5

We serve Diprotin A CAS:90614-48-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Diprotin A

Chemical Name:Diprotin A
CAS.NO:90614-48-5
Synonyms:Diprotin A
L-Isoleucyl-L-prolyl-L-isoleucine
 
Physical and Chemical Properties:
Density 1.14 g/cm3
Boiling Point 583.1ºC at 760 mmHg
Molecular Formula C17H31N3O4
Molecular Weight 341.44600
Flash Point 306.5ºC
Index of Refraction 1.517
 
Specification:
Appearance:White to off-white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:A dipeptidyl aminopeptidase IV (DPP IV) inhibitor. Enhances recruitment of CXCR4 positive circulating endothelial progenitors to myocardium.



Contact us for information like Diprotin A chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,L-Isoleucyl-L-prolyl-L-isoleucine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,L-Isoleucyl-L-prolyl-L-isoleucine Use and application,L-Isoleucyl-L-prolyl-L-isoleucine technical grade,usp/ep/jp grade.


Related News: This dosage form may also support combination therapy modalities.? To date, over 400 patients have been dosed with the oral formulation of rigosertib in clinical trials.? Combination therapy of oral rigosertib with azacitidine, the standard of care in HR-MDS, has also been studied. Currently, oral rigosertib is being developed as a combination therapy together with azacitidine for patients with higher-risk MDS who require HMA therapy.?(S)-(-)-α,α-Diphenyl-2-pyrrolidinemethanol manufacturer Combining its core technological advantages such as ammonia oxidation, phosgenation, and fluorination, the company actively enters the field of fine and functional chemicals, and expands its focus to include polymer additives, replacement of phenolic polymer material monomers, and coating preservatives.Diethylsilanediol supplier The risk to the UK population has been raised from very low to low, according to Public Health England, which says the country is “well prepared for new diseases”.azetidine vendor In recent years, there has been a relatively concentrated concentration of intermediate companies listed on the capital market. Most of the fund-raising projects are aimed at breaking through the bottleneck of production capacity to meet growing demand, and the entire industry has shown a vigorous development momentum.The man recently traveled to Wuhan, China, and sought medical care soon after his return to Massachusetts.